XWEL
XWELL Inc.
NASDAQ: XWEL · HEALTHCARE · DIAGNOSTICS & RESEARCH
$1.18
+2.61% today
Updated 2026-04-30
Market cap
$9.43M
P/E ratio
—
P/S ratio
0.32x
EPS (TTM)
$-5.08
Dividend yield
—
52W range
$0 – $2
Volume
10.0M
WallStSmart proprietary scores
28
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.0
Quality
C+2.0
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$7.00
+493.22%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at -58.20%
- Negative free cash flow $-748000.00
- Revenue declining -4.20% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $55.94M | $30.11M | $33.90M | $29.21M | $29.21M |
| Net income | $-32.84M | $-27.74M | $-16.85M | $-16.99M | $-9.28M |
| EPS | — | — | — | — | $-5.08 |
| Free cash flow | $-31.02M | $-18.45M | $-12.80M | $-11.68M | $-748000.00 |
| Profit margin | -58.70% | -92.14% | -49.72% | -58.17% | -58.20% |
Peer comparison
Smart narrative
XWELL Inc. trades at $1.18. Our Smart Value Score of 28/100 indicates the stock is weak. TTM revenue stands at $29.21M. with profit margins at -58.20%.
Frequently asked questions
What is XWELL Inc.'s stock price?
XWELL Inc. (XWEL) trades at $1.18.
Is XWELL Inc. overvalued?
Smart Value Score 28/100 (Grade F, Strong Sell).
What is the price target of XWELL Inc. (XWEL)?
The analyst target price is $7.00, representing +493.2% upside from the current price of $1.18.
What is XWELL Inc.'s revenue?
TTM revenue is $29.21M.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.32x
ROE-159.00%
Beta0.96
50D MA$1.16
200D MA$0.93
Shares out0.01B
Float0.01B
Short ratio—
Avg volume10.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—